Evidence map›Paper›PMID 36843626›Full record

ArticleInternational cancer conference journal2023

COVID arm that appeared in the contralateral upper extremity after mRNA-1273 booster inoculation.

Tomomi Sanomachi, Hitomi Sumiyoshi Okuma, Kan Yonemori

Erratum issuedOpen access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International cancer conference journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tomomi Sanomachi5-1-1 Tsukiji, Chuo-Ku, Tokyo, Japan Department of Medical Oncology, Department of International Clinical Development, Clinical Research Support Office, National Cancer Center Hospital.
Hitomi Sumiyoshi Okuma5-1-1 Tsukiji, Chuo-Ku, Tokyo, Japan Department of Medical Oncology, Department of International Clinical Development, Clinical Research Support Office, National Cancer Center Hospital.
Kan Yonemori5-1-1 Tsukiji, Chuo-Ku, Tokyo, Japan Department of Medical Oncology, Department of International Clinical Development, Clinical Research Support Office, National Cancer Center Hospital.
Japan Clinical Cancer Research Organization · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the findings of a 60-year-old female patient with metastatic breast cancer who presented with severe edema and neuralgia in the contralateral arm after receiving the third COVID-19 vaccine dose. The patient did not report any reaction to the first two doses of the BNT162b2 (Pfizer-BioNTech) vaccine. However, after a booster dose with the mRNA-1273 (Moderna) vaccine, the patient developed a high fever persisting for one week after the shot, and sequential severe swelling, inflammation, and pain in the contralateral arm lasting for three weeks.

Indexed as

COVID armmRNA-1273 booster inoculationRemote location

Identifiers

PMID36843626
PMCPMC9939858
OpenAlexW4321617932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.